+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Epidemiologic characteristics and risk factors for invasive Haemophilus influenzae type b disease in a population with high vaccine efficacy



Epidemiologic characteristics and risk factors for invasive Haemophilus influenzae type b disease in a population with high vaccine efficacy



Pediatric Infectious Disease Journal 8(6): 343-346



Before the introduction of vaccination the annual incidence of Haemophilus influenzae b invasive disease in children <5 years old in Finland was 52/100 000. Of these 46% had meningitis, 29% epiglottitis and 25% other forms of disease. Most cases of meningitis occurred between 0 and 2 years old with the peak at <1 year old whereas the peak for epiglottitis was at 3.5 years old.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 001825186

Download citation: RISBibTeXText

PMID: 2787493

DOI: 10.1097/00006454-198906000-00002


Related references

Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. Clinical Infectious Diseases 22(6): 1069-1076, 1996

Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatric Infectious Disease Journal 20(3): 300-305, 2001

Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up. Pediatric Infectious Disease Journal 14(11): 978-981, 1995

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Socioeconomic Risk Factors for Invasive Haemophilus influenzae Type b Disease. Journal of Infectious Diseases 165: S11-S15, 1992

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Safety, Immunogenicity, and Efficacy in Infancy of Oligosaccharide Conjugate Haemophilus influenzae Type b Vaccine in a United States Population: Possible Implications for Optimal Use. Journal of Infectious Diseases 165: S139-S143, 1992

Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. Journal of Pediatrics 108(6): 887-896, 1986

Efficacy of Haemophilus influenzae Type b conjugate vaccines, risk factors for invasive Hib disease and under-vaccination in the United States. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 160, 1995

A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan. Vaccine 36(38): 5678-5684, 2018

Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatric Infectious Disease Journal 8(5): 297-302, 1989

Prevention of invasive Haemophilus influenzae type b disease: lessons from vaccine efficacy trials. Vaccine 9 Suppl: S17, 1991

Invasive Haemophilus influenzae disease in a rural area since the introduction of the Haemophilus influenzae type B vaccine. Journal of Investigative Medicine 50(1): 127A, 2002

Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. Journal of Infectious Diseases 153(1): 17-26, 1986

Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group. Lancet 338(8764): 395-398, 1991

Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatric Infectious Disease Journal 11(8): 610-613, 1992

Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era. Clinical and Vaccine Immunology 19(5): 766-771, 2012